[1] Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease[J]. N Earl J Med, 2009, 360(23): 2445-2454. [2] Bracke KR, D'hulst AI, Maes T, et al. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice[J]. J Immunol, 2006, 177(7):4350-4359. [3] Di Stefano A, Caramori G, Gnemmi I, et a1. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients[J]. Clin Exp Immuno1, 2009, 157(2): 316-324. [4] Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity[J]. Eur J Immunol, 2008, 38(4): 921-924. [5] Barnes PJ. The cytokine network in chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol, 2009, 41(6): 631-638. [6] Isajevs S, Taivans I, Strazda G, et al. Decreased FOXP3 expression in small airways of smokers with COPD[J]. Eur Respir J, 2009, 33(1): 61-67. [7] Smyth LJ, Starkey C, Vestbo J, et al. CD4 -regulatory T-cells in COPD patients[J]. Chest, 2007, 132(1): 156-163. [8] Hackett TL, Holloway R, Holgate ST, et al. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study[J]. Respir Res, 2008, 9: 47. [9] Barceló B, Pons J, Ferrer JM, et al. Phenotypic characterisation T-lymphocytes in COPD : abnormal CD4+ CD25+ regulatory T-lymphocyte response to tobacco smoking[J]. Eur Respir J, 2008, 31(3): 555-562. [10]Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease[J]. Lancet, 2011, 378(9795):1015-1026. [11]Xu L, Kitani A, Fuss I, et a1. Cutting edge: regulatory T cells induce CD4+ CD25-Foxp3-T cells or are self-induced to become Thl7 cells in the absence of exogenous TGF-beta[J]. J Immuno1, 2007, 178(11): 6725-6729. |